Xavier M Teitsma

Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial

J. W. J. Bijlsma, Paco M J Welsing, Thasia Woodworth et al. · The Lancet · 2016 · 246 citations

Life Sciences, Immunology, Pharmacotherapy +11

Tocilizumab as monotherapy or combination therapy for treating active rheumatoid arthritis: a meta-analysis of efficacy and safety reported in randomized controlled trials

Xavier M Teitsma, Anne Karien Marijnissen, J. W. J. Bijlsma et al. · Arthritis Research & Therapy · 2016 · 52 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors

Xavier M Teitsma, Johannes W. G. Jacobs, Paco M J Welsing et al. · Annals of the Rheumatic Diseases · 2018 · 52 citations

Medicine, Internal Medicine, Pharmacotherapy +15

Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology

Xavier M Teitsma, Wei Yang, Johannes W. G. Jacobs et al. · Arthritis Research & Therapy · 2018 · 38 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials

Maxime M. A. Verhoeven, Marjolein JH de Hair, Janneke Tekstra et al. · Annals of the Rheumatic Diseases · 2019 · 23 citations

Medicine, Pharmacology, Pharmacotherapy +14